{
  "report_rows": [
    {
      "kpi": "Q1 FY27 net bookings",
      "prediction": "BEAT",
      "answer": "pred ~$1.44B vs. cons $1.42B",
      "confidence": "LOW"
    },
    {
      "kpi": "Q1 FY27 GAAP net revenue",
      "prediction": "BEAT",
      "answer": "pred ~$1.70B vs. cons $1.68B",
      "confidence": "LOW"
    },
    {
      "kpi": "Q1 FY27 diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.66 vs. cons $0.65",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY27 net-bookings outlook",
      "prediction": "UNKNOWN",
      "answer": "guide ~$0.00B vs. cons $8.10B (FY27; expected to be withheld pending transaction)",
      "confidence": "HIGH"
    },
    {
      "kpi": "FY27 diluted-EPS outlook",
      "prediction": "UNKNOWN",
      "answer": "guide ~$0.00 vs. cons $4.10 (FY27; expected to be withheld pending transaction)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Merger closing timetable / remaining approvals",
      "prediction": "UNKNOWN",
      "answer": "guide ~$210.00 per share vs. cons $210.00 per share (transaction period; no precise closing-date update expected)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 0.1,
  "day1_confidence": "LOW",
  "day5_residual_pct": -0.2,
  "day5_path": "STABILIZE",
  "day5_rationale": "A modest operating beat of ~$0.02B on bookings and ~$0.01 on EPS should not drive estimate revisions while FY27 guidance remains withheld; with $210.00 cash consideration versus a ~$208.91 reference price, the five-day result should stabilize near the merger-arbitrage spread rather than follow through.",
  "day5_confidence": "MEDIUM"
}